131 related articles for article (PubMed ID: 7181474)
61. Preliminary observations pertaining to polyadenylation of rhinovirus RNA.
Nair CN; Owens MJ
J Virol; 1974 Feb; 13(2):535-7. PubMed ID: 4359303
[TBL] [Abstract][Full Text] [Related]
62. An antiviral furanoquinone from Paulownia tomentosa Steud.
Kang KH; Huh H; Kim BK; Lee CK
Phytother Res; 1999 Nov; 13(7):624-6. PubMed ID: 10548761
[TBL] [Abstract][Full Text] [Related]
63. Inhibition of poliovirus uncoating by disoxaril (WIN 51711).
Zeichhardt H; Otto MJ; McKinlay MA; Willingmann P; Habermehl KO
Virology; 1987 Sep; 160(1):281-5. PubMed ID: 2820136
[TBL] [Abstract][Full Text] [Related]
64. Inhibitory effects of antiviral compounds on respiratory syncytial virus replication in vitro.
Kawana F; Shigeta S; Hosoya M; Suzuki H; De Clercq E
Antimicrob Agents Chemother; 1987 Aug; 31(8):1225-30. PubMed ID: 3307618
[TBL] [Abstract][Full Text] [Related]
65. Antiviral activity and metabolism of the castanospermine derivative MDL 28,574, in cells infected with herpes simplex virus type 2.
Ahmed SP; Nash RJ; Bridges CG; Taylor DL; Kang MS; Porter EA; Tyms AS
Biochem Biophys Res Commun; 1995 Mar; 208(1):267-73. PubMed ID: 7887939
[TBL] [Abstract][Full Text] [Related]
66. Selective inhibition of arthropod-borne and arenaviruses in vitro by 3'-fluoro-3'-deoxyadenosine.
Smee DF; Morris JL; Barnard DL; Van Aerschot A
Antiviral Res; 1992 Jun; 18(2):151-62. PubMed ID: 1365816
[TBL] [Abstract][Full Text] [Related]
67. Specific inhibition of viral ribonucleic acid replication by Gliotoxin.
Miller PA; Milstrey KP; Trown PW
Science; 1968 Jan; 159(3813):431-2. PubMed ID: 4294481
[TBL] [Abstract][Full Text] [Related]
68. PDTC inhibits picornavirus polyprotein processing and RNA replication by transporting zinc ions into cells.
Lanke K; Krenn BM; Melchers WJG; Seipelt J; van Kuppeveld FJM
J Gen Virol; 2007 Apr; 88(Pt 4):1206-1217. PubMed ID: 17374764
[TBL] [Abstract][Full Text] [Related]
69. Des-aspartate-angiotensin I exerts antiviral effects and attenuates ICAM-1 formation in rhinovirus-infected epithelial cells.
Ang LT; Tan LY; Chow VT; Sim MK
Eur J Pharmacol; 2012 May; 683(1-3):310-5. PubMed ID: 22387854
[TBL] [Abstract][Full Text] [Related]
70. Biological Evaluation of Uridine Derivatives of 2-Deoxy Sugars as Potential Antiviral Compounds against Influenza A Virus.
Krol E; Wandzik I; Krejmer-Rabalska M; Szewczyk B
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28777309
[TBL] [Abstract][Full Text] [Related]
71. In vitro surrogate models to aid in the development of antivirals for the containment of foot-and-mouth disease outbreaks.
Osiceanu AM; Murao LE; Kollanur D; Swinnen J; De Vleeschauwer AR; Lefebvre DJ; De Clercq K; Neyts J; Goris N
Antiviral Res; 2014 May; 105():59-63. PubMed ID: 24583031
[TBL] [Abstract][Full Text] [Related]
72. Antiviral activity of Spirulina maxima against herpes simplex virus type 2.
Hernández-Corona A; Nieves I; Meckes M; Chamorro G; Barron BL
Antiviral Res; 2002 Dec; 56(3):279-85. PubMed ID: 12406511
[TBL] [Abstract][Full Text] [Related]
73. Inhibition of replication and cytopathic effect of human T cell lymphotropic virus type III/lymphadenopathy-associated virus by 3'-azido-3'-deoxythymidine in vitro.
Nakashima H; Matsui T; Harada S; Kobayashi N; Matsuda A; Ueda T; Yamamoto N
Antimicrob Agents Chemother; 1986 Dec; 30(6):933-7. PubMed ID: 2434024
[TBL] [Abstract][Full Text] [Related]
74. Anti-rhinovirus-specific activity of the alpha-sympathomimetic oxymetazoline.
Koelsch S; Tschaikin M; Sacher F
Arzneimittelforschung; 2007; 57(7):475-82. PubMed ID: 17803062
[TBL] [Abstract][Full Text] [Related]
75. The effects of concanavalin A on the early events of infection by rhinovirus type 2 and poliovirus type 2.
Lonberg-Holm K
J Gen Virol; 1975 Sep; 28(3):313-27. PubMed ID: 170375
[TBL] [Abstract][Full Text] [Related]
76. Inhibition of enterovirus 71 replication and viral 3C protease by quercetin.
Yao C; Xi C; Hu K; Gao W; Cai X; Qin J; Lv S; Du C; Wei Y
Virol J; 2018 Jul; 15(1):116. PubMed ID: 30064445
[TBL] [Abstract][Full Text] [Related]
77. Picornavirus RNA is protected from cleavage by ribonuclease during virion uncoating and transfer across cellular and model membranes.
Groppelli E; Levy HC; Sun E; Strauss M; Nicol C; Gold S; Zhuang X; Tuthill TJ; Hogle JM; Rowlands DJ
PLoS Pathog; 2017 Feb; 13(2):e1006197. PubMed ID: 28166307
[TBL] [Abstract][Full Text] [Related]
78. In vitro and in vivo activities of WIN 54954, a new broad-spectrum antipicornavirus drug.
Woods MG; Diana GD; Rogge MC; Otto MJ; Dutko FJ; McKinlay MA
Antimicrob Agents Chemother; 1989 Dec; 33(12):2069-74. PubMed ID: 2559655
[TBL] [Abstract][Full Text] [Related]
79. Anti-herpesvirus activity of the acyclic nucleoside 9-(1,3-dihydroxy-2-propoxymethyl)guanine.
Smee DF; Martin JC; Verheyden JP; Matthews TR
Antimicrob Agents Chemother; 1983 May; 23(5):676-82. PubMed ID: 6307132
[TBL] [Abstract][Full Text] [Related]
80. Inhibition of vesicular stomatitis virus replication by delta 12-prostaglandin J2 is regulated at two separate levels and is associated with induction of stress protein synthesis.
Pica F; De Marco A; De Cesare F; Santoro MG
Antiviral Res; 1993 Mar; 20(3):193-208. PubMed ID: 8385894
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
